Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Innovative therapy for chronic myelogenous leukemia

¹Department of Medicine, University of Minnesota, Minneapolis, USA.

Hematology/Oncology Clinics of North America

|April 2, 1998

Summary

Innovative therapies for chronic myelogenous leukemia (CML) combine transplantation with other treatments. These approaches target the bcr/abl gene or leverage allogeneic disparity for improved CML remission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation.

Transplantation and cellular therapy·2021

Same author

Potato Late Blight in the Columbia Basin: An Economic Analysis of the 1995 Epidemic.

Plant disease·2019

Same author

Implications of Sexual Reproduction for Phytophthora infestans in the United States: Generation of an Aggressive Lineage.

Plant disease·2019

Same author

Influence of Timing of Harvest in Relation to Haulm Killing and Planting Date on Potato Tuber Rot Caused by Phytophthora infestans.

Plant disease·2019

Same author

Prevalence and Impact of SDHI Fungicide Resistance in Alternaria solani.

Plant disease·2019

Same author

Tubulogenesis of co-cultured human iPS-derived endothelial cells and human mesenchymal stem cells in fibrin and gelatin methacrylate gels.

Biomaterials science·2017

Area of Science:

Hematology
Oncology
Molecular Biology

Background:

Chronic myelogenous leukemia (CML) pathogenesis involves the bcr/abl gene rearrangement.
Existing CML therapies often involve transplantation, with innovative strategies focusing on graft purging or post-transplant treatment.
Allogeneic disparity has been observed to play a role in maintaining CML remissions.

Purpose of the Study:

To review the rationale and supporting data for innovative CML therapies.
To discuss future strategies in CML treatment.

Main Methods:

Review of existing studies on CML pathogenesis and treatment modalities.
Analysis of data supporting novel therapeutic approaches.
Discussion of future research directions.

Main Results:

Two innovative therapy categories are based on the bcr/abl gene.
A third category utilizes allogeneic disparity for remission maintenance.
The article synthesizes data supporting these innovative approaches.

Conclusions:

Innovative CML therapies are evolving, focusing on targeted gene therapies and allogeneic approaches.
Further research and strategic development are crucial for advancing CML treatment outcomes.

Related Experiment Videos